These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8522836)

  • 1. Immunotherapy with Mycobacterium vaccae combined with second line chemotherapy in drug-resistant abdominal tuberculosis.
    Prior JG; Khan AA; Cartwright KA; Jenkins PA; Stanford JL
    J Infect; 1995 Jul; 31(1):59-61. PubMed ID: 8522836
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy of tuberculosis with Mycobacterium vaccae NCTC 11659.
    Stanford JL; Stanford CA
    Immunobiology; 1994 Oct; 191(4-5):555-63. PubMed ID: 7713570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal tuberculosis due to multidrug-resistant Mycobacterium tuberculosis.
    Esposito S; Bosis S; Canazza L; Tenconi R; Torricelli M; Principi N
    Pediatr Int; 2013 Apr; 55(2):e20-2. PubMed ID: 23679177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa.
    Onyebujoh PC; Abdulmumini T; Robinson S; Rook GA; Stanford JL
    Respir Med; 1995 Mar; 89(3):199-207. PubMed ID: 7746913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis.
    Stanford J; Stanford C; Grange J
    Front Biosci; 2004 May; 9():1701-19. PubMed ID: 14977580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Durban Immunotherapy Trial Group.
    Lancet; 1999 Jul; 354(9173):116-9. PubMed ID: 10408487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 1. Newly-diagnosed pulmonary disease.
    Corlan E; Marica C; Macavei C; Stanford JL; Stanford CA
    Respir Med; 1997 Jan; 91(1):13-9. PubMed ID: 9068812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis.
    Dlugovitzky D; Fiorenza G; Farroni M; Bogue C; Stanford C; Stanford J
    Respir Med; 2006 Jun; 100(6):1079-87. PubMed ID: 16278080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis?
    Stanford JL; Stanford CA; Grange JM; Lan NN; Etemadi A
    Respir Med; 2001 Jun; 95(6):444-7. PubMed ID: 11421500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 2. Chronic or relapsed disease.
    Corlan E; Marica C; Macavei C; Stanford JL; Stanford CA
    Respir Med; 1997 Jan; 91(1):21-9. PubMed ID: 9068813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological basis for the introduction of immunotherapy with Mycobacterium vaccae into the routine treatment of TB.
    Dlugovitzky D; Stanford C; Stanford J
    Immunotherapy; 2011 Apr; 3(4):557-68. PubMed ID: 21463195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapeutic effect of Mycobacterium vaccae on multi-drug resistant pulmonary tuberculosis].
    Luo Y; Lu S; Guo S
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Feb; 23(2):85-8. PubMed ID: 11778496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New treatment modalities for the cavitary lesion of drug-resistant tuberculous].
    Cikirikçioğlu YB
    Tuberk Toraks; 2003; 51(1):91-3. PubMed ID: 15100911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whither Mycobacterium vaccae?
    Reichman LB
    Lancet; 1999 Jul; 354(9173):90. PubMed ID: 10408480
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjunct immunotherapies for tuberculosis.
    Uhlin M; Andersson J; Zumla A; Maeurer M
    J Infect Dis; 2012 May; 205 Suppl 2():S325-34. PubMed ID: 22457298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis.
    Huang CY; Hsieh WY
    Hum Vaccin Immunother; 2017 Sep; 13(9):1960-1971. PubMed ID: 28604170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abdominal tuberculosis.
    Lazarus AA; Thilagar B
    Dis Mon; 2007 Jan; 53(1):32-8. PubMed ID: 17224321
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of tuberculosis: update 2010.
    Yew WW; Lange C; Leung CC
    Eur Respir J; 2011 Feb; 37(2):441-62. PubMed ID: 20847074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-97.
    Mayo RE; Stanford JL
    Trans R Soc Trop Med Hyg; 2000; 94(5):563-8. PubMed ID: 11132390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of artificial pneumothorax in the treatment of patients with pulmonary tuberculosis with multiple drug-resistant Mycobacteria].
    Chukanov VI; Mishin VIu; Sigaev AT; Vasil'eva IA; Osadchaia OA; Perfil'ev AV; Naumova AN; Bagdasarian TR
    Probl Tuberk Bolezn Legk; 2004; (8):22-4. PubMed ID: 15478553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.